Asson-Batres MA, Ryzhov S, Tikhomirov O, Duarte CW, Congdon CB, Lessard CR, McFarland S, Rochette-Egly C, Tran TL, Galindo CL, Favreau-Lessard AJ, Sawyer DB

Am. J. Physiol. Heart Circ. Physiol.. 2016 Jun;310(11):H1773-89

Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines.

Carrier M, Joint M, Lutzing R, Page A, Rochette-Egly C

PLoS ONE. 2016 ;11(6):e0157290

Nuclear and extranuclear effects of vitamin A.

Iskakova M, Karbyshev M, Piskunov A, Rochette-Egly C

Can J Physiol Pharmacol. 2015 Dec;93(12):1065-75

Retinoic acid receptors: from molecular mechanisms to cancer therapy.

di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P, Nervi C

Mol Aspects Med. 2015 Feb;41:1-115

Retinoic acid signaling and mouse embryonic stem cell differentiation: Cross talk between genomic and non-genomic effects of RA.

Rochette-Egly C

Biochim Biophys Acta. 2015 Jan;1851(1):66-75

Phosphorylation of the retinoic acid receptor RARgamma2 is crucial for the neuronal differentiation of mouse embryonic stem cells.

Al Tanoury Z, Gaouar S, Piskunov A, Ye T, Urban S, Jost B, Keime C, Davidson I, Dierich A, Rochette-Egly C

J Cell Sci. 2014 May 1;127(Pt 9):2095-105

Production and characterization of a retinoic acid receptor RARgamma construction encompassing the DNA binding domain and the disordered N-terminal proline rich domain.

Martinez-Zapien D, Delsuc MA, Trave G, Lutzing R, Rochette-Egly C, Kieffer B

Protein Expr Purif. 2014 Mar;95:113-20

Genes involved in cell adhesion and signaling: a new repertoire of retinoic acid receptor target genes in mouse embryonic fibroblasts.

Al Tanoury Z, Piskunov A, Andriamoratsiresy D, Gaouar S, Lutzing R, Ye T, Jost B, Keime C, Rochette-Egly C

J Cell Sci. 2014 Feb 1;127(Pt 3):521-33

Retinoic acid receptor subtype-specific transcriptotypes in the early zebrafish embryo.

Samarut E, Gaudin C, Hughes S, Gillet B, de Bernard S, Jouve PE, Buffat L, Allot A, Lecompte O, Berekelya L, Rochette-Egly C, Laudet V

Mol Endocrinol. 2014 Feb;28(2):260-72

History of retinoic acid receptors.

Benbrook DM, Chambon P, Rochette-Egly C, Asson-Batres MA

Subcell Biochem. 2014;70:1-20

Nuclear and extra-nuclear effects of retinoid acid receptors: how they are interconnected.

Piskunov A, Al Tanoury Z, Rochette-Egly C

Subcell Biochem. 2014;70:103-27

The nutritional importance of liposoluble compounds, such as vitamin A. Foreword.

Asson-Batres MA, Rochette-Egly C

Subcell Biochem. 2014;70:v-vi.

Vitamin A and retinoid signaling: genomic and nongenomic effects.

Al Tanoury Z, Piskunov A, Rochette-Egly C

J Lipid Res. 2013 Jul;54(7):1761-75

Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid.

Gauchotte G, Lacomme S, Brochin L, Tournier B, Cahn V, Monhoven N, Piard F, Klein M, Martinet N, Rochette-Egly C, Vignaud JM

Virchows Arch. 2013 Jun;462(6):619-32

Phosphorylation of the retinoic acid receptor alpha induces a mechanical allosteric regulation and changes in internal dynamics.

Chebaro Y, Amal I, Rochel N, Rochette-Egly C, Stote RH, Dejaegere A

PLoS Comput Biol. 2013 Apr;9(4):e1003012

Regulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway.

Zassadowski F, Rochette-Egly C, Chomienne C, Cassinat B

Cell Signal. 2012 Dec;24(12):2369-77

p38alphaMAPK interacts with and inhibits RARalpha: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.

Gianni M, Peviani M, Bruck N, Rambaldi A, Borleri G, Terao M, Kurosaki M, Paroni G, Rochette-Egly C, Garattini E

Leukemia. 2012 Aug;26(8):1850-61

A retinoic acid receptor RARalpha pool present in membrane lipid rafts forms complexes with G protein alphaQ to activate p38MAPK.

Piskunov A, Rochette-Egly C

Oncogene. 2012 Jul 12;31(28):3333-45

Nuclear retinoic acid receptors: conductors of the retinoic acid symphony during development.

Samarut E, Rochette-Egly C

Mol Cell Endocrinol. 2012 Jan 30;348(2):348-60

Detection of variable levels of RARalpha and RARgamma proteins in pluripotent and differentiating mouse embryonal carcinoma and mouse embryonic stem cells.

Buchanan FQ, Rochette-Egly C, Asson-Batres MA

Cell Tissue Res. 2011 Oct;346(1):43-51

Genome-wide in silico identification of new conserved and functional retinoic acid receptor response elements (direct repeats separated by 5 bp).

Lalevee S, Anno YN, Chatagnon A, Samarut E, Poch O, Laudet V, Benoit G, Lecompte O, Rochette-Egly C

J Biol Chem. 2011 Sep 23;286(38):33322-34

The molecular physiology of nuclear retinoic acid receptors. From health to disease.

Duong V, Rochette-Egly C

Biochim Biophys Acta. 2011 Aug;1812(8):1023-31

Evolution of nuclear retinoic acid receptor alpha (RARalpha) phosphorylation sites. Serine gain provides fine-tuned regulation.

Samarut E, Amal I, Markov GV, Stote R, Dejaegere A, Laudet V, Rochette-Egly C

Mol Biol Evol. 2011 Jul;28(7):2125-37

New role for granulocyte colony-stimulating factor-induced extracellular signal-regulated kinase 1/2 in histone modification and retinoic acid receptor alpha recruitment to gene promoters: relevance to acute promyelocytic leukemia cell differentiation.

Cassinat B, Zassadowski F, Ferry C, Llopis L, Bruck N, Lainey E, Duong V, Cras A, Despouy G, Chourbagi O, Beinse G, Fenaux P, Rochette Egly C, Chomienne C

Mol Cell Biol. 2011 Apr;31(7):1409-18

Vinexinss, an atypical "sensor" of retinoic acid receptor gamma signaling: union and sequestration, separation, and phosphorylation.

Lalevee S, Bour G, Quinternet M, Samarut E, Kessler P, Vitorino M, Bruck N, Delsuc MA, Vonesch JL, Kieffer B, Rochette-Egly C

FASEB J. 2010 Nov;24(11):4523-34

Phosphorylation control of nuclear receptors.

Lalevee S, Ferry C, Rochette-Egly C

Methods Mol Biol. 2010;647:251-66.

Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.

Gianni' M, Boldetti A, Guarnaccia V, Rambaldi A, Parrella E, Raska I Jr, Rochette-Egly C, Del Sal G, Rustighi A, Terao M, Garattini E

Cancer Res. 2009 Feb 1;69(3):1016-26

A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters.

Bruck N, Vitoux D, Ferry C, Duong V, Bauer A, de The H, Rochette-Egly C

EMBO J. 2009 Jan 7;28(1):34-47

Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs).

Rochette-Egly C, Germain P

Nucl Recept Signal. 2009 May 8;7:e005.

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.

Nasr R, Guillemin MC, Ferhi O, Soilihi H, Peres L, Berthier C, Rousselot P, Robledo-Sarmiento M, Lallemand-Breitenbach V, Gourmel B, Vitoux D, Pandolfi PP, Rochette-Egly C, Zhu J, de The H

Nat Med. 2008 Dec;14(12):1333-42

Dysregulation of elastin expression by fibroblasts in pulmonary emphysema: role of cellular retinoic acid binding protein 2.

Plantier L, Rochette-Egly C, Goven D, Boutten A, Bonay M, Leseche G, Fournier M, Crestani B, Boczkowski J

Thorax. 2008 Nov;63(11):1012-7

Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors.

Bour G, Lalevee S, Rochette-Egly C

Trends Cell Biol. 2007 Jun;17(6):302-9

Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamm

Parrella E, Gianni M, Fratelli M, Barzago MM, Raska I Jr, Diomede L, Kurosaki M, Pisano C, Carminati P, Merlini L, Dallavalle S, Tavecchio M, Rochette-Egly C, Terao M, Garattini E

Mol Pharmacol. 2006 Sep;70(3):909-24

Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7.

Gaillard E, Bruck N, Brelivet Y, Bour G, Lalevee S, Bauer A, Poch O, Moras D, Rochette-Egly C

Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9548-53

The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells.

Bastien J, Plassat JL, Payrastre B, Rochette-Egly C

Oncogene. 2006 Mar 30;25(14):2040-7.

P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription.

Gianni M, Parrella E, Raska I Jr, Gaillard E, Nigro EA, Gaudon C, Garattini E, Rochette-Egly C

EMBO J. 2006 Feb 22;25(4):739-51

Retinoic acid metabolism and signaling pathways in the adult and developing mouse testis.

Vernet N, Dennefeld C, Rochette-Egly C, Oulad-Abdelghani M, Chambon P, Ghyselinck NB, Mark M

Endocrinology. 2006 Jan;147(1):96-110

Phosphorylation of the retinoid x receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity.

Bruck N, Bastien J, Bour G, Tarrade A, Plassat JL, Bauer A, Adam-Stitah S, Rochette-Egly C

Cell Signal. 2005 Oct;17(10):1229-39

Dynamic combinatorial networks in nuclear receptor-mediated transcription.

Rochette-Egly C

J Biol Chem. 2005 Sep 23;280(38):32565-8

Vinexin beta interacts with the non-phosphorylated AF-1 domain of retinoid receptor gamma (RARgamma) and represses RARgamma-mediated transcription.

Bour G, Plassat JL, Bauer A, Lalevee S, Rochette-Egly C

J Biol Chem. 2005 Apr 29;280(17):17027-37

Retinoic acid and arsenic trioxide cooperate for apoptosis through phosphorylated RXR alpha.

Tarrade A, Bastien J, Bruck N, Bauer A, Gianni M, Rochette-Egly C

Oncogene. 2005 Mar 31;24(14):2277-88.

Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II.

Despouy G, Bastie JN, Deshaies S, Balitrand N, Mazharian A, Rochette-Egly C, Chomienne C, Delva L

J. Biol. Chem.. 2003 Feb;278(8):6355-62

Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.

Parrado A, Despouy G, Kraïba R, Le Pogam C, Dupas S, Choquette M, Robledo M, Larghero J, Bui H, Le Gall I, Rochette-Egly C, Chomienne C, Padua RA

Nucleic Acids Res.. 2001 Dec;29(24):4901-8

The novel co-activator CRABPII binds to RARalpha and RXRalpha via two nuclear receptor interacting domains and does not require the AF-2 'core'.

Bastie JN, Despouy G, Balitrand N, Rochette-Egly C, Chomienne C, Delva L

FEBS Lett.. 2001 Oct;507(1):67-73

Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex.

Delva L, Bastie JN, Rochette-Egly C, Kraïba R, Balitrand N, Despouy G, Chambon P, Chomienne C

Mol. Cell. Biol.. 1999 Oct;19(10):7158-67

Expression of retinoid receptor genes and proteins in non-small-cell lung cancer.

Picard E, Seguin C, Monhoven N, Rochette-Egly C, Siat J, Borrelly J, Martinet Y, Martinet N, Vignaud JM

J Natl Cancer Inst. 1999 Jun 16;91(12):1059-66.